Skip to main content
. 2026 Oct 4;27(19):8861. doi: 10.3390/ijms27198861
BBB Blood–Brain Barrier
CL Cutaneous Leishmaniasis
CP Cysteine Protease
HAT Human African Trypanosomiasis
hCatB Human Cathepsin B
hCatL Human Cathepsin L
ML Mucocutaneous Leishmaniasis
NTD Neglected Tropical Disease
PAINS Pan-Assay Interference Compounds
POI Protein of Interest
PROTAC Proteolysis Targeting Chimera
SAR Structure–Activity Relationship
SI Selectivity Index
VL Visceral Leishmaniasis
VSG Variant Surface Glycoprotein
WHO World Health Organization